FreeTender
Accepting bidsgrant

RFAs: Advancing AI-Based Biomarker Research for Chronic Disease Prediction and Personalised Treatment

Issued by European Commission · via fundsforNGOs — grants & funding calls

Verify & apply on the official portal →
Published
3 Nov 2026
Closes
17 Feb 2027
Reference
rfas-advancing-ai-based-biomarker-research-for-chronic-disease-prediction-and-pe
Sector
Healthcare & Pharma

At a glance

European Commission has published a funding call in healthcare & pharma: “RFAs: Advancing AI-Based Biomarker Research for Chronic Disease Prediction and Personalised Treatment”. Submissions close on 17 February 2027, 96 days from today. Quote reference rfas-advancing-ai-based-biomarker-research-for-chronic-disease-prediction-and-pe in any correspondence with the buyer. FreeTender has recorded 421 notices from this buyer since 2026, 405 of them currently open. There are 33,453 open healthcare & pharma notices on FreeTender. Bids are submitted to the buyer through fundsforNGOs — grants & funding calls, not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

Who can apply

Eligible applicants include entities from EU member states, EFTA countries, and Associated Countries.

Details

The European Commission is inviting proposals for the Horizon Europe call focusing on the development of predictive biomarkers of disease progression and treatment response using Artificial Intelligence (AI) methodologies for chronic non-communicable diseases. This initiative, under the Horizon 2027 Health Cluster, aims to enhance clinical research and personalized medicine for better health outcomes. Applications are open from 29 October 2026, with a two-stage deadline process ending on 17 February 2027 and 16 September 2027. This call focuses on utilizing AI to develop predictive biomarkers that can accurately assess disease progression and treatment responses in chronic non-communicable diseases, excluding cancer. The initiative aims to address unmet clinical needs by integrating data from various biomarkers and clinical studies to deliver innovative solutions for personalized healthcare. While specific funding amounts are not detailed, successful proposals will support collaborative projects that pave the way for future innovations in personalized medicine. Participation from small and medium-sized enterprises (SMEs) is encouraged to strengthen their scientific and technological capabilities. Eligible applicants include entities from EU member states, EFTA countries, and Associated Countries. Proposals must be led by entities from these regions and should involve multidisciplinary collaborations. This initiative is crucial for advancing personalized medicine, improving health outcomes, and addressing the complexities of chronic non-communicable diseases. By developing AI-driven biomarkers, the opportunity aims to revolutionize clinical research and healthcare delivery. What is the main objective of this call? The call aims to develop predictive biomarkers using AI to improve the assessment of disease progression and treatment response in chronic non-communicable diseases. Who can apply for this funding? Entities based in the EU, EFTA, and Associated Countries are eligible to apply. What is the deadline for proposal submission? The two-stage deadlines are 17 February 2027 and 16 September 2027. Are there specific funding amounts per project? The funding amounts are not specified in the source. What types of projects are encouraged? Projects that involve multidisciplinary collaboration and innovative use of AI in developing predictive biomarkers. Eligible applicants should carefully review the official guidelines and prepare their proposals in compliance with the outlined objectives and requirements. For more detailed information, visit the official opportunity page.

Context for bidders

We hold 421 notices from European Commission, going back to August 2026 — 405 of them still open. They buy mostly in IT & Telecom, Water & Environment and Healthcare & Pharma. There are 33,453 open Healthcare & Pharma tenders. This one closes in 96 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →